IN8bio CFO granted 56,250 stock options at $1.58
IN8bio, Inc. reported that its Chief Financial Officer, Patrick McCall, received an employee stock option grant for 56,250 options to buy common stock at an exercise price of $1.58 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IN8bio, Inc. reported that its Chief Financial Officer, Patrick McCall, received an employee stock option grant for 56,250 options to buy common stock at an exercise price of $1.58 per share. Following this grant, he holds 56,250 derivative securities directly.
The option vests in four equal parts, with 25% of the shares vesting on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, as long as he continues providing service through each vesting date. The option expires on May 9, 2036.
Insider Trade Summary
Grant/Award: 56,250 shares
Grant/Award
1 txn
Insider
McCall Patrick
Role
CHIEF FINANCIAL OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 56,250 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 56,250 contracts (Direct)
Footnotes (1)
- F1. Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date.
Key Figures
Options Granted: 56,250 options
Exercise Price: $1.58 per share
Post-transaction derivative holdings: 56,250 derivative securities
+2 more
5 metrics
Options Granted
56,250 options
Employee stock option grant to CFO on May 9, 2026
Exercise Price
$1.58 per share
Strike price for 56,250 options
Post-transaction derivative holdings
56,250 derivative securities
Total options held directly after grant
Vesting installments
25% on four dates
Vesting on Nov 9, 2026; May 9, 2027; Nov 9, 2027; May 9, 2028
Option Expiration
May 9, 2036
Expiry date of employee stock option grant
Key Terms
Employee Stock Option, exercise price, vest, derivative securities, +1 more
5 terms
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
exercise price financial
"conversion_or_exercise_price: "1.5800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"shares subject to the option shall vest on each of November 9, 2026"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative securities financial
"total_shares_following_transaction: "56250.0000" (derivative)"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did IN8bio (INAB) disclose about CFO Patrick McCall’s latest equity award?
IN8bio disclosed that CFO Patrick McCall received an employee stock option grant for 56,250 shares at a $1.58 exercise price. These options are a compensation award, not an open-market purchase, and increase his potential ownership if the options eventually vest and are exercised.
How many stock options did IN8bio (INAB) grant to its CFO and at what price?
IN8bio granted CFO Patrick McCall 56,250 employee stock options with an exercise price of $1.58 per share. This means he can buy up to 56,250 IN8bio common shares at $1.58 if the options vest and are exercised before expiration.
What is the vesting schedule for Patrick McCall’s IN8bio (INAB) stock options?
The 56,250 stock options vest in four equal installments of 25% each. Vesting dates are November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, contingent on McCall continuing to provide service through each vesting date.
When do the newly granted IN8bio (INAB) stock options to the CFO expire?
The employee stock options granted to CFO Patrick McCall expire on May 9, 2036. He can only exercise vested portions of the 56,250 options before that date; any unexercised options after the expiration date will lapse and become worthless.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates